Skip to Content


In the US, Duloxetine (duloxetine systemic) is a member of the drug class serotonin-norepinephrine reuptake inhibitors and is used to treat Anxiety, Back Pain, Bipolar Disorder, Chronic Fatigue Syndrome, Chronic Pain, Depression, Diabetic Peripheral Neuropathy, Fibromyalgia, Generalized Anxiety Disorder, Hot Flashes, Major Depressive Disorder, Osteoarthritis, Pain, Peripheral Neuropathy, Persistent Depressive Disorder, Small Fiber Neuropathy, Somatoform Pain Disorder and Urinary Incontinence.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories


Antidepressant: Selective serotonin and noradrenalin reuptake inhibitor (SSNRI)

Chemical Names

(+)-(S)-N-Metyl-3-(1-naphtyloxy)-3-(2-tienyl)propylamin (IUPAC)

(+)-(S)-N-metyl-gamma-(1-naphtyloxy)-2-tiophenepropylamine (WHO)

(S)-N-Metyl-3-(1-naphtyloxy)-3-(2-tienyl)propan-1-amine (BAN)

Foreign Names

  • Duloxetinum (Latin)
  • Duloxetin (German)
  • Duloxetine (French)
  • Duloxetina (Spanish)

Generic Names

  • Duloxetine (OS: BAN)
  • LY 248686 (Lilly) (IS)
  • Xeristar (IS)
  • Duloxetine (PH: USP 41)
  • Duloxetine Hydrochloride (OS: BAN, USAN, JAN)
  • LY 248686 HCl (Lilly) (IS)
  • LY-223332 (IS)
  • LY-223743 (IS)
  • LY-223994 (IS)
  • LY-227750 (IS)
  • LY-227942 (IS)
  • LY-228993 (IS)
  • LY-264452 (IS)
  • LY-264453 (IS)
  • LY-267826 (IS)
  • Duloxétine (chlorhydrate de) (PH: Ph. Eur. 9)
  • Duloxetine Hydrochloride (PH: BP 2018, USP 41)
  • Duloxetine hydrochloride (PH: Ph. Eur. 9)
  • Duloxetinhydrochlorid (PH: Ph. Eur. 9)
  • Duloxetini hydrochloridum (PH: Ph. Eur. 9)

Brand Names


BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.